POMT1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: POMT1–related disorders belong to the group of dystroglycanopathies characterized by a proximally pronounced muscular dystrophy with structural or functional involvement of the brain and/or the eyes.